These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32122862)

  • 1. Evaluation of solubility and dissolution of lamotrigine using lipid based microparticulate carriers: An in-vitro analysis.
    Islam N; Irfan M; Zahoor AF; Syed HK; Khan IU; Iqbal MS; Rasul A; Abbas N; Hussain A; Mohsin NUA; Qayyum MA; Arshad MS; Inam S
    Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):299-306. PubMed ID: 32122862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and Evaluation of Novel Solid Lipid Microparticles for the Sustained Release of Ofloxacin.
    Hooda A; Sradhanjali M; Popsy
    Pharm Nanotechnol; 2017; 5(4):329-341. PubMed ID: 29278216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine Nanoparticle Laden Polymer Composite Oral Dissolving Films for Improving Therapeutic Potential of the Hydrophobic Antiepileptic Molecule.
    Shankar Raman S; Narayanan VHB; Durai R
    Assay Drug Dev Technol; 2021 Jan; 19(1):2-16. PubMed ID: 33216611
    [No Abstract]   [Full Text] [Related]  

  • 4. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
    Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X
    AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation.
    Sarfraz RM; Ahmad M; Mahmood A; Akram MR; Abrar A
    Drug Des Devel Ther; 2017; 11():3083-3096. PubMed ID: 29123380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
    Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
    Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment.
    Abdelmonem R; El-Enin HAA; Abdelkader G; Abdel-Hakeem M
    Drug Deliv; 2023 Dec; 30(1):2163321. PubMed ID: 36579655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
    Yadav VR; Suresh S; Devi K; Yadav S
    J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Self-nanoemulsifying Drug Delivery System for Poorly Water Soluble Tolbutamide: Development, Optimization and Pharmacodynamic Studies.
    Pandita D; Kumari N; Lather V
    Pharm Nanotechnol; 2017; 5(4):285-300. PubMed ID: 28925888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
    Salunkhe SS; Bhatia NM; Bhatia MS
    Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization.
    El-Kamel AH; Al-Fagih IM; Alsarra IA
    J Microencapsul; 2007 Aug; 24(5):457-75. PubMed ID: 17578735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
    Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B
    Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate.
    Albertini B; Passerini N; Di Sabatino M; Vitali B; Brigidi P; Rodriguez L
    Eur J Pharm Sci; 2009 Mar; 36(4-5):591-601. PubMed ID: 19150403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
    Rizwanullah M; Amin S; Ahmad J
    J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.